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Summary.-Clinical-pathologic-genetic studies were performed on 3 kindreds
showing the familial atypical multiple mole-melanoma syndrome (FAMMM).
Findings showed vertical transmission, including father-to-son, of cutaneous
malignant melanoma and/or FAMMM moles with no sex predilection. A broad
spectrum of clinical signs characterizing the phenotype ranged from an apparent
lack of disease expression through minimal, moderate, and florid manifestations.
An extreme example was a patient with 9 separate primary melanomas in 18 years.
The FAMMM moles were histologically compound nevocellular nevi with varying
degrees of dyslIasia of the melanocytes, an increased occurrence of fibroplasia, and
chronic inflammation within the papillary dermis. Of further interest was marked
variation in the degree of dysplasia in moles between and within families.
These observations, when coupled with recent reports by others, are consistent
with an autosomal dominant gene showing markedly variable expressivity. Manage-
ment of these patients is difficult, as one cannot be certain which moles require
biopsy and then, following histological study, which will require wider excision.
Studies of the FAMMM syndrome should deal carefully with its natural history,
including the patient's lifelong susceptibility to multiple malignant melanomas, and
the possibility that cancer of other anatomic sites may be integral components of this
hereditary cancer syndrome.
THE FIRST description of familial
cutaneous malignant melanoma (CMM)
was provided by Cawley (1952) who
described this disease in a father and 2 of
his 3 children. It has since become appar-
ent that a hereditary form of melanoma
exists (Lynch & Krush, 1968; Lynch &
Frichot, 1978; Lynch et al., 1975; Lynch,
1972, 1976; Anderson, 1971). Most studies
of familial melanoma have involved vari-
ably sized series of consecutively ascer-
tained melanoma probands. The frequency
of melanoma was then evaluated in their
families and compared with controls.
Almost uniformly lacking in these earlier
studies were detailed clinical descriptions
of the families, including cancer of all
anatomic sites, associated diseases, and/or
cutaneous anomalies. It is not surprising,
therefore, that heterogeneity in familial
melanoma has only recently been appre-
ciated (Lynch & Frichot, 1978; Lynch
et al., 1975).
This report provides a detailed updating
of our ongoing clinical-pathological-gen-
etic investigations of 3 families who mani-
fest the familial atypical multiple mole-
melanoma syndrome (FAMMM) (Frichot
& Lynch, 1977; Lynch et al., 1978b), also
referred to as the B-K Mole Syndrome by
Clark and associates (Clark et al., 1978;
Reimer et al., 1978).FAMILIAL MELANOMA (FAMMM)
MATERIALS AND METHODS
Our standard protocol for cancer genetic
investigations has been used in studies of
familial melanoma (Lynch, 1972; 1976).
This protocol incorporates the use of detailed
questionnaires which are mailed to all the
proband's maternal and paternal relatives,
once clinical-genetic and pathologic evalua-
tion of melanoma has been completed in the
proband. Extension of the pedigree includes
a search for cancer of all anatomic sites,
in addition to documentation of all major
causes ofmorbidity and mortality. A detailed
description of the cutaneous phenotype has
been emphasized. Whenever possible, per-
sonal examinations of these relatives are
then performed by a clinical oncologist-
geneticist and a dermatologist. A registered
nurse interviews each patient in order to
update and to corroborate information
obtained from the questionnaires. All pri-
mary medical and pathology documents,
including pathology slides, are then secured
for review by our collaborating dermato-
pathologist.
These methodologies have been used to
study 3 informative kindreds, 2 ascertained
in Nebraska and one from the state of
Washington. We have not had experience
with any similar families although, as
already mentioned, remarkable kindreds
have been reported in the literature (Clark
et al., 1978; Reimer et al., 1978). Since this
particular clinical-genetic entity has been
identified only recently, it is not yet possible
to estimate its gene frequency.
FAMILY STU DY RESULTS
Family 1. The proband (Fig. 1, IV-4)
was first described by Lynch & Krush
(1968). The proband was then aged 26 and
he had had 4 histologically verified
cutaneous malignant melanomas (CMMs)
on the skin of his legs, arms, and torso. A
fifth malignant melanoma (nodular,
Clark's level IV) was diagnosed on his
mid-back during this examination. The
patient had reddish hair, light com-
plexion, blue eyes, and he had had very
heavy sun exposure, having worked as a
lifeguard in high school and college as well
as having participated as a collegiate
swimmer. He was noted to have multiple
moles, and reported a similar cutaneous
phenotype in his siblings (Fig. 1, IV-5,
IV-6). However, the significance of the
FAMMM phenotype was not recognized
at that time; the family was subsequently
evaluated in 1977 and reported as an
example ofthe FAMMM syndrome (Lynch
et al., 1978b).
A more recent evaluation ofthe proband
and several of his relatives was accomp-
lished in 1979, when the proband was
aged 38. Fig. 2 shows a front view and
Fig. 3 a close-up of the proband's back.
His clinical lesions were extremely varied,
and were mostly on the trunk and
proximal areas of the extremities. There
were very few lesions on the exposed areas
of the face and neck. The vast majority
were regular, tan-to-brown macular lesions
under 1 cm in diameter. There were many
much darker lesions, sometimes almost
black. These lesions were usually variable
in outline and either macularorpapular. In
addition, there were a smaller number of
atypical lesions, characteristically < 1 cm
in diameter, oval in outline, erythae-
matous, and usually macular. At the
periphery of the lesions, there were tan-
to-brown macular areas within the oval
perimeters. The atypical mole in Fig. 3
(see arrow) was biopsied and showed
histological features compatible with a
FAMMM mole. The skin lesion was a com-
pound nevus (Fig. 4a). The melanocytes at
the epidermal-dermal junction showed
evidence of mild dysplasia. The papillary
dermis (Fig. 4b) showed fibroplasia and
new blood vessel formation. Chronic in-
flammation in the papillary dermis was
minimal. Since his last examination in
1968 until now, he has had 4 additional
CMMs, all histologically verified, making a
total of 9 CMMs in 18 years.
The proband's daughter (Fig. 1, V-1)
was examined in 1977, when she was aged
7 years. She showed several brown moles
on the skin of her back, all of which were
round and regular (Fig. 5a). It is note-
worthy that her parents stated that these
lesions began to appear around the age
of 2. Particular attention was given to this
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age because the proband's mother stated
that this seemed to be the age of onset of
moles in her 3 children (Fig. 1, IV-4, IV-5,
IV-6). This girl had shown normal growth
and development, and was of average
intelligence. Examination in 1979 at the
age of 9 (Fig. 5b) showed a striking evolu-
tion ofthe lesions on her back as evidenced
by the appearance of new moles. The
lesions were few in number. They appeared
to be slightly larger thanordinary macular
and papular nevi, with varying shades of
tan and brown. One of these lesions was
1 cm in diameter and appeared papular
and larger than the other lesions (Fig. 5b,
see arrow). This lesion was excised and
histological findings were consonant with
a FAMMM mole. It was a compound nevus
(Fig. 6a). There was moderate dysplasia
at the epidermal-dermal junction. The
papillary dermis (Fig. 6b) showed evidence
of fibroplasia and some mature-looking
lymphocytes which seemed to be more
numerous than in normal nevi.
One of the proband's sisters (Fig. 1,
IV-5) was examined by one of us (HTL)
in 1977. This lady showed a cutaneous
phenotype which was virtually identical
to that in her brother. She has had 4
histologically verified CMMs, the first of
these diagnosed in 1974. We diagnosed her
fourth CMM (histologically verified) on her
back in 1977. A second sister (Fig. 1, IV-6)
was not personally examined by us. How-
ever, the history indicates that she also
had a cutaneous phenotype strikingly
similar to her brother, the proband, and
her sister. Because of this history, we
strongly encouraged this 29-year-old lady
to be evaluated by a dermatologist, who
excised multiple moles showing the char-
acteristic findings of the FAMMM histo-
logy. A CMM was also removed from her
left flank.
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Fic.n. 2. vFront view of the probandl (IV4) in 1'amily 1. Note the pres-ence of multiple moles, several
of ,hiClh are strikinglyk atypi(cal.
'I'he inother (Fig. 1, 111-2) of these
patients was examine(d by one of tus
(HTIE) in 1 977 wrhen she was aged 60. She
had her first (MNM at the age of 47 and a
second at the age of 56. Her history indi-
cated t,hat multiple atypical moles had
previouisly been excise(1. Our examiniation
did not reveal atypical moles. HowAever,
histological review of the previouisly
excised moles showed some of themn to be
consistent with FAMMM.
The proband's maternal auLnt, (Fig. 1,
111-3) had a hist,ory of a cuttaneous phenio-
type consistent with the FAMMM svrn-
(Irome. Hist,opathological review of these
moles showed findings consistent w\ith
FAMMM. She had a histologically verified
(MM at the age of 45 anId died f'rom mneta-
stases at the age of 55.
The proband's 54-year-ol(l second
cousin (Fig. 1, III-1) showed no evidence
of the FAMMM phenotype. Hoowever, she
had a histologically verifie(d (MM at the
age of 54. The mother of the second(
cotusin (Fig. 1, II-1) lha(d a (MM inl her
history at the age of 5:3 andldied of pan-
creatic carcinoma at 68. The proband's
grandfather (Fig. 1, 11-2) died of histo-
logically verified pancreatic carcinoma at
the age of 68. We do not have a reliable
historv of his ctutaneous phenotype.
This family showed vertical trans-
mission of the FAMMM phenotype
(FAMMM moles and/or C'MM) throuigh 4
generations (Fig. 1, 11-1, III 1, 111-2,
IVr-4, IV5-5, I-6, V-I) with verification of
FAMMM moles in several of these
patients, incltllding the proband's (laughter
(Fig. 1, V-i), thereby showing 3 genera-
tions of FAMMM moles (histologically
verified). The proband showed unustual
tolerance to (MM, as evidenced by lhis
survival after 9 verified CMMs, one of
which was a noduilar malignant melanoma,
(lark's level IV, d(uring an 18-year period.
Family 2. The proband (Fig. 7, 111-I)
was examinled by a (lermatology colleague
who reporte(l muiltiple aCtyypical moles con-
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FIG. 3. Closeup of the ski l of the back ofthe probar.d from Figure 1. The arrow indicates an atypical
mole (I cm in greatest diameter) whielh histologically slowed findings consistent with a FAMMM
mole (Fig. 4).
sistent with our original description of the
FAMMM syndrome (Lynch et al., 1978b).
She had 2 verified CMMs at the age of 22.
Our pathology review of her moles showed
characteristic features ofFAMMM (Fig. 8).
This patient's 21-year-old brother (Fig.
7, 111-3) had 3 histologically verified
CMMs. His history showed a cutaneous
phenotype characteristic of the FAMMM
syndrome. Review ofthe pathology report
of his atypical moles showed them to be
consistent with FAMMM histology. A
sister of these patients (Fig. 7, 111-4) had
a history of CMM at the age of 26.
The proband's father (Fig. 7, 11-2) had
a history of CMM at the age of 30, and
multiple atypical moles. It is of interest
that the proband's mother (Fig. 7, 11-3)
had a history of CMM at the age of 48.
This is therefore an example of con-
nubial melanoma. There was a history of
melanoma in the proband's paternal
grandmother (Fig. 7, 1-3) and was histo-
logically verified in the proband's mater-
nal grandfather (Fig. 7, 1-4). A further
study of this family is in progress by the
National Cancer Institute.
Family 3. The proband (Fig. 9, 11-1)
had histologically verified CMM at the age
of 54. Our examination revealed no
evidence ofthe FAMMM cutaneous pheno-
type. This patient diedofmetastatic malig-
nant melanoma at the age of 61. One of her
brothers (Fig. 9, 111-3) had no evidence of
atypical moles, but we diagnosed a basal-
cell carcinoma from the skin of his neck.
A second brother (Fig. 9, 111-4) had histo-
logically verified carcinoma of the lung,
from which he died at the age of 52. We
had no opportunity to examine this
patient. A third brother (Fig. 9, 111-5) had
a history of CMM at the age of 53, and a
second (histologically verified) primary
malignant neoplasm of the lung. He died
from the latter at the age of 62. We did
not have information about his cutaneous
phenotype.
A 70-vear-old sister of the proband
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(a) (b)
Vie.. 4. Compoundl nevus seen in Fig. 3. (a) vith melanocytic dysplasia at (lermal-epi(lermal juniction,
fibroplasia of papillary clermis, and minimal clhronic inflammation (H & E, x 95). (b) Fibroplasia
of papillary (lermis an(l minimal lymphocytie infiltration (H & E, x 198).
(Fig. 9, 111-6) was examined by us and
found to be completely negative for the
FAMMM phenotype and for any cancer.
However, it is noteworthy that she had a
daughter (Fig. 9, IV-4) who had a CMM
histologically verified at the age of 23, and
multiple atypical moles consistent clinic-
ally and histologically with the FAMMM
phenotype. This lady also had a daughter
(Fig. 9, V-1) who showed a cutaneous
phenotype consistent with the FAMMM
syndrome (Fig. ]1Oa). She was examined
by us at the age of 17, when multiple
biopsies were obtained of the atypical
moles, with findings histologically con-
sistent with FAMMM. It is ofinterest that
2 years later, the patient developed a
Clark's Level IV malignant melanoma at
the site of a prior biopsy of a FAMMM
mole (Fig. 10a, arrow).
5
Her 2 brothers (Fig. 9, V-2, V-3) were
examined by us and each had clinical and
histological evidence of the FAMMM
phenotype. The proband's nephew (Fig. 9,
IV-6) had histologically verified Hodgkin's
disease at the age of 28.
A niece of the proband (Fig. 9, IV-5)
had a history of more than 30 atypical
moles, which had been surgically removed
but have not yet been examined by us.
This patient has 2 children (Fig. 9, V-4,
V-5) with clinical and histological findings
consistent with FAMMM.
In summary, this family showed clinical
and histological evidence of the FAMMM
syndrome in members of 2 generations,
and CMM verified in 3 generations. A note-
worthy aspect of the pedigree is that one
of its members (Fig. 9, 111-6) showed no
evidence of FAMMM, yet was the pro-
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FIG. 5.-Daughter (Vl) of proband in Family 1 at the age of 7 (a) and at the age of 9 (b). Though
the photographs are not to the same scale, there is a clear increase in moles during this 2-year inter-
val, with a new prominent lesion (arrow) which was popular and larger than the other lesions and
which histologically was found to be a FAMMM mole (Fig. 6).
genitor of this syndrome and had 2 sib-
lings (Fig. 9, 111-1, 111-5) with CMM.
The Table summarizes the histological
observations of FAMMM moles in these 3
kindreds. We have compared them with
descriptions of the histopathology of the
B-K moles described by Clark et al. (1978).
DISCUSSION
Studies of the genetics of malignant
melanoma in man (Lynch & Frichot,
1978) as with nearly all varieties of cancer
(Lynch, 1976) have been aided signifi-
cantly by animal studies. For example,
Gordon (1931), in studies on hybrid fish,
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(a) (b)
FIG. 6. Compound nevus seen in Fig. 5. (a) Melanocytic dysplasia primarily at dermal-epidermal
interface. Prominent lymphocytic infiltration in papillary dermis (H & E, x 122). (b) Melanocytic
dysplasia. Lymphocytic infiltration and fibroplasia of papillary dermis (H & E, x 188).
TABLE. Comparison of histologic features
of nevi in the FAMMM syndrome and
the B-K Mole syndrome
Histological features
FAMMM syndrome
Compound nevus
Melanocytic dysplasia
(mild to severe)
Fibroplasia-papillary
dermis (variable)
Lymphocytic infiltrate-
papillary dermis
(variable to absent)
Histology not always
similar to a regressing
malignant melanoma or
halo nevus
B-K Mole syndrome
Compound nevus
Atypical melanocytic
hyperplasia
Fibroplasia-papillary
dermis
Lymphocytic infiltrate;
papillary dermis
Histology like a
regressing malignant
melanoma or halo
nevus
showed melanoma risk to be enhanced in
the F1 cross between one parent carrying a
macromelanophore-spotting gene (Xipho-
phoros maculatus) and the other parent
from a strain lacking this gene (X. hellerii).
When a back cross was made between the
F1 hybrid and the parent strain in which
the spotting gene originated, melanoma
developed which was less severe than that
in the hybrid, presumably due to a pro-
tective effect of the residual genotype
which had evolved in the X. maculatus
strain. Finally, a back cross to the
parental strain which lacked the macro-
melanophore gene caused severe melanosis
and melanoma in progeny inheriting the
macromelanophore-spotting gene but lack-
ing "protection" from the residual geno-
type of the X. hellerii parent. A review of
this work and others on the genetic and
biochemical basis of malignant melanoma
at the infra-human level included the pine
snake, Drosophila, swine, dogs, horses and
cattle (Siciliano & Perlmutter, 1972).
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FIG. 7. Pedigree of Family 2, slhowing
malignant melanoma in 3 generations, with
connubial malignant melanoma in the
parents of the sibship of generation III.
Multiple primary melanomas, early age of
onset, and FAMIMM moles were noted in the
probancl and her brother. Symbols as in
Fig. 1, plus: K, Kidney cancer; 49, Cuirrent
age; d. 58, Age at (tlatl.
14
f 26
26
At the human level, earlier studies of
familial melanoma failed to give attention
to clinical-pathologic differences rele-
vant to cutaneous phenotype or associated
cancer. For example, Anderson (1971)
studied an aggregate of 74 documented
pedigrees offamilial malignant melanoma,
and concluded that the genetics of this
disease were complex and probably in-
volved several autosomal loci, in addition
to a possible cytoplasmic component
transmitted through carrier women.
Southerland (1975) identified 18 families
prone to melanoma, and suggested that
the genetics were consistent with an auto-
somal dominant gene showing incomplete
penetrance. Wallace et al. (1971) studied
42 melanoma pedigrees and concluded
that polygenic inheritance provided a
more acceptable explanation for the
genetics of this disease. Gleicher et al.
(1979) reviewed the world literature on
the subject and found 92 reported ex-
amples of familial melanoma. They con-
cluded that an autosomal dominant was
the best explanation for most of these
FIG. 8. Compound nevus from Family 2, with marked dysplasia of melanocytes at dermal-epidermal
interface. Fibroplasia and capillary proliferation of papillary (lermis, fewv clhronic iniflammatory
cells are noted (H & E, x 240).
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FIG. 9. Pedigree ofFamily 3, showing malignant melanoma verified in 3 generations, with histological
verification of FAMMM moles in individuals affected with malignant melanoma as well as indi-
viduals at ri3k for this disease. Noteworthy is patient 111-6 who, at the age of 70, had no evidence
of malignant melanoma and who had no atypical moles, but had siblings affected with malignant
melanoma and was the progenitor of 2 generations ofaffected individuals. Symbols as in Figs I and
7, plus: Ho, Hodgkin's; Lsa, Lymphosarcoma; Lu, Lung; Ov, Ovary; Pr, Prostate; Sk, Skin;
St, Stomach.
reports. The fact that genetic conclusions
differed among the several malignant-
melanoma family studies confirms our
own observation of genetic heterogeneity
in this disease (Lynch et al., 1975).
We have described the clinical-patho-
logical-genetic features in 3 families with
the FAMMM syndrome. Vertical trans-
mission, including father to son, of CMM
and/or FAMMM moles was verified. There
was no significant sex predilection. There
was a broad spectrum of clinical signs
which characterized the phenotype. These
ranged from an apparent lack of disease
expression in one of our genetically in-
formative patients (Fig. 9, 111-6) to florid
manifestations in the proband in Family 1
(Fig. 1, IV-4). The sum total of these
observations is compatible with an auto-
somal dominant gene of very variable
expressivity.
The absence of disease in an alleged
gene carrier has recently been discussed
by Matsunaga (1978) in the model of
hereditary retinoblastoma. He has in-
ferred that, given the relatively high
frequency of resistant carriers of the
retinoblastoma gene, genes determining
host resistance to retinoblastoma are non-
specific and may affect the growth of
tumours in general. If this were the case,
one might expect penetrance and ex-
pressivity of the retinoblastoma gene
within families to be correlated with the
frequency of cancer of all sites among
relatives. In other words, these observa-
tions agree with the hypothesis that
patients at high cancer risk may harbour
in their genotypes an array of cancer-
resistant genes (so-called suppressor genes)
which could have a major effect on
penetrance of the cancer component of
the phenotype. This hypothesis therefore
suggests polygenic systems independent
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FIG. 10-.The skin of the back of Patient V-I in Fig. 9. The arrow in A shows an atypical mole which
pathologically was a FAMMM mole, when biopsied at the age of 17. Two years later, at the age of
19 (B), this lesion has progressed (arrow) and biopsy showed histological evidence ofa Clark's Level
IV malignant melanoma.
of the major cancer-predisposing gene
which has a more general effect on cancer
susceptibility or resistance. We believe
that this reasoning could explain the so-
called "skipped" generation as evidenced
in our informative unaffected gene
"carrier" patient discussed above. We
have observed this phenomenon in other
dominantly inherited cancer syndromes
(Lynch, 1976).
Sites of CMM in our kindreds favoured
unexposed areas of the body. This was in
contrast to their more frequent occurrence
in sun-exposed areas in the sporadic
variety of malignant melanoma (Kripke,
1979). The CMMs in our FAMMM patients
were exclusively of the superficial spread-
ing or nodular variety, with a depth of
invasion ranging from Clark's Levels I to
IV.
The natural history of this disease is
also variable. There was evidence of the
onset of FAMMM moles in childhood in
Family 1. Malignant melanomas were of
strikingly early age of onset and often
multiple, with a lifelong susceptibility to
these lesions in the face of apparent
unusual long survival. Prolonged survival
may be characteristic of hereditary
malignant melanoma. A more extreme
instance of this phenomenon was seen in
2 siblings with xeroderma pigmentosum
and verified metastatic malignant melan-
oma who underwent spontaneous re-
gression (Lynch et al., 1978a).
The histopathology of the FAMMM
moles showed them to be compound nevo-
cellular nevi with varying degrees of
dysplasia of the melanocytes. These
lesions usually showed evidence of fibro-
plasia and chronic inflammation within
the papillary dermis. There was consider-
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able variation in the degree of dysplasia
in nevi between and within families.
Specifically, certain family members had
compound nevi with marked dysplasia,
whilst other relatives had less dysplasia of
the melanocytes.
The histological appearance of such
lesions, and subsequent changes that are
seen in the evolution of these lesions,
favours the interpretation of an immune
response in the host. This pathological
process may be an expression of a similar
event in halo nevi or a regressing malig-
nant melanoma.
The features seen in these nevi are
similar to the changes referred to as the
B-K mole syndrome described by Clark
et al. (1978) and Reimer et al. (1978). These
authors use the term "atypical melano-
cytic hyperplasia". This term is considered
to be synonymous with "melanocytic
dysplasia". Histologically, one sees indi-
vidual melanocytes or clusters of melano-
cytes, that show cytological abnormalities.
These atypical melanocytes are seen
primarily at the dermal-epidermal inter-
face. These then are melanocytes with
some potential for malignant change,
although the exact malignant propensity
is not known.
A serious dilemma exists in the patho-
genesis FAMMM, distinguishing the
benign from the malignant mole. This
poses a crucial question for management,
namely "Which moles should you biopsy
on the basis of clinical inspection and
then, on the basis of histology, which
require wider excision?" Unfortunately,
this issue has not yet been resolved.
While the descriptive terminology of
the FAMMM syndrome emphasizes its
association with atypical moles and malig-
nant melanoma, we believe that it is
prudent to give additional attention to
other cancer associations. For example,
in Family 1 (Fig. lI) there was pancreatic
carcinoma in siblings in the direct genetic
line, whereas lung cancer and Hodgkin's
disease occurred in relatives in Family 3
(Fig. 9). It is important that all reports of
the FAMMM syndrome include a pains-
taking appraisal of cancer at all anatomic
sites, so that patterns of tumour asso-
ciations might be recognized. It is also
imperative that we explore possible rela-
tionships between the FAMMM syndrome
and other familial/hereditary forms of
malignant melanoma, in addition to
sporadic malignant melanoma. In short,
a question which requires more study is,
"What is the clinical, pathological and
aetiological significance of the FAMMM
syndrome in relation to oncology in
general and to all aetiological varieties of
malignant melanoma in particular?"
An important question pertains to the
philosophy of treatment of FAMMM-
affected patients. One particularly won-
ders about the role of conservative vs
radical treatment of malignant melan-
omas. This question must be tempered by
the unusually benign clinical course in
some of our patients. Another issue is the
need for restriction of solar radiation
exposure in FAMMM patients. We must
consider here data suggesting that malig-
nant melanoma (except lentio maligna
melanoma) may differ from other skin
cancers in that it may be elicited by
intense and shorter periods of solar
radiation exposure, rather than the more
frequent finding of cumulative lifetime
exposure in non-melanoma skin cancer.
A putative "solar circulating factor" (Lee
& Merrill, 1970) has been proposed for
certain malignant melanomas occurring
in non-sun exposed areas. In the case of
the FAMMM syndrome, this might be
conditioned by the presumptive genetic
proclivity to carcinogenesis in the atypical
moles.
The de novo occurrences of melanoma in
our patients at high risk but lacking
FAMMM moles is of interest. These could
be chance occurrences. However, we
believe that it probably represents hetero-
geneity of this putative dominant pleio-
tropic gene, which does not express the
atypical mole component ofthe syndrome
in some ofthe melanoma-affected patients.
This problem is in some respects similar to
that of dominantly inherited Gardner's
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syndrome, where colon cancer may occur
in a patient lacking the cutaneous and/or
osseous component of this cancer-asso-
ciated genodermatosis. These considera-
tions are discussed since it has been
suggested (Clark etal., 1978; Reimer et al.,
1978) that the pathology findings in the
Atypical moles are essential for diagnosis
of this hereditary malignant melanoma-
associated syndrome. We prefer to con-
sider the pathology of the moles as only
one, albeit important, component of the
syndrome, its presence not being man-
datory for diagnosis of the FAMMM
syndrome. We believe it prudent to base
the diagnosis on the sum total of the
clinical and pathological findings, and the
pedigree. Soberingly, family history has
been sorely neglected in most clinical
cancer studies (Lynch et al., 1979).
Families of the type we have described
should serve as excellent models for
studies of genetic-environmental inter-
action in careinogenesis.
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